Team Singularity Female
Team Singularity Female 7 – 13 TENSTAR Nova
7
13
26 Oct 2021
18:15
TENSTAR Nova
Veto Process
No veto information available
Team Singularity Female
| Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|
| ESTEE | 261 | 19 / 16 / 3 | 162 | 75% | 3 - 0 | 40% |
| minemosynE | 206 | 15 / 16 / 1 | 142 | 55% | 1 - 3 | 23% |
| Lakhesis | 215 | 13 / 18 / 5 | 143 | 70% | 2 - 1 | 15% |
| Ked | 203 | 13 / 17 / 2 | 126 | 65% | 1 - 1 | 11% |
| Nariel | 144 | 9 / 17 / 4 | 107 | 55% | 3 - 5 | 22% |
| Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|
| ESTEE | 261 | 19 / 16 / 3 | 162 | 75% | 3 - 0 | 40% |
| minemosynE | 206 | 15 / 16 / 1 | 142 | 55% | 1 - 3 | 23% |
| Lakhesis | 215 | 13 / 18 / 5 | 143 | 70% | 2 - 1 | 15% |
| Ked | 203 | 13 / 17 / 2 | 126 | 65% | 1 - 1 | 11% |
| Nariel | 144 | 9 / 17 / 4 | 107 | 55% | 3 - 5 | 22% |
Team Singularity Female
| Agent | Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|---|
|
ESTEE | 261 | 19 / 16 / 3 | 162 | 75% | 3 - 0 | 40% |
|
minemosynE | 206 | 15 / 16 / 1 | 142 | 55% | 1 - 3 | 23% |
|
Lakhesis | 215 | 13 / 18 / 5 | 143 | 70% | 2 - 1 | 15% |
|
Ked | 203 | 13 / 17 / 2 | 126 | 65% | 1 - 1 | 11% |
|
Nariel | 144 | 9 / 17 / 4 | 107 | 55% | 3 - 5 | 22% |
| Agent | Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|---|
|
ESTEE | 261 | 19 / 16 / 3 | 162 | 75% | 3 - 0 | 40% |
|
minemosynE | 206 | 15 / 16 / 1 | 142 | 55% | 1 - 3 | 23% |
|
Lakhesis | 215 | 13 / 18 / 5 | 143 | 70% | 2 - 1 | 15% |
|
Ked | 203 | 13 / 17 / 2 | 126 | 65% | 1 - 1 | 11% |
|
Nariel | 144 | 9 / 17 / 4 | 107 | 55% | 3 - 5 | 22% |